Stockreport

Vaxart Announces Its Oral Flu Vaccine Significantly Reduced Rate of Influenza Infection in Phase 2 Challenge Study

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF Vaxart influenza vaccines are manufactured using a high-yield recombinant process rather than in chicken eggs like most influenza vaccines currently on t [Read more]